Skip to Main content Skip to Navigation
Poster communications

Chiral purity limitation: discovery of a partial solid solution

Abstract : Since S-Ibuprofen (S-Ibu) has been proved to have a higher therapeutic effect than R-Ibuprofen (R-Ibu) [1], the chiral separation of racemic Ibuprofen (rac-Ibu) -the current marketed drug- has become of great interest. In this work, chiral resolution of rac-Ibu was performed by using S-α-MethylBenzylAmine (S-αMBA) in order to form the diastereomeric salt S-Ibu-S-αMBA. The chiral purity obtained from various experiments seemed limited to a maximum of 87% of S-Ibu-S-αMBA. XRPD analysis suggested the existence of a partial solid solution, but the phase diagram published in literature [2] only exhibits a simple eutectic. Investigations performed through DSC measurements allowed the construction of Tammann graph and evidenced the existence of a partial solid solution enriched in S-Ibu-S-αMBA. This partial solid solution is the cause of the limitation in chiral purity. The updated phase diagram has been recently published [3]. [1] A. M. Evans, Clinical Rheumatology, 2001, vol. 20, p. 9-14. [2] E. J. Ebbers et al., Tetrahedron: Asymmetry, 1997, vol. 8, p. 4047-4057. [3] L. Marc et al., Crystals, 2021, vol. 11, p. 1188.
Document type :
Poster communications
Complete list of metadata

https://hal-normandie-univ.archives-ouvertes.fr/hal-03455543
Contributor : Laureline MARC Connect in order to contact the contributor
Submitted on : Monday, November 29, 2021 - 5:03:13 PM
Last modification on : Wednesday, March 9, 2022 - 3:56:05 PM

File

MARC Laureline Poster Chirafun...
Files produced by the author(s)

Identifiers

  • HAL Id : hal-03455543, version 1

Citation

Laureline Marc, Chrystal Lopes, Jean-Marie Schneider, Morgane Sanselme, Gérard Coquerel. Chiral purity limitation: discovery of a partial solid solution. Chirafun, Nov 2021, Rennes, France. ⟨hal-03455543⟩

Share

Metrics

Record views

29

Files downloads

14